Increased dose of echinocandins for invasive fungal infections: bonanza for the patient or the pharmaceutical industry?
Chandrasekar
P H
PH
D000935:Antifungal Agents / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004345:Drug Industry / Q000191:economics; D054714:Echinocandins; D005656:Fungal Proteins / Q000627:therapeutic use*; D006801:Humans; D009181:Mycoses / Q000188:drug therapy*; D010456:Peptides, Cyclic / Q000627:therapeutic use*
D000935:Antifungal Agents; D054714:Echinocandins; D005656:Fungal Proteins; D010456:Peptides, Cyclic; C007572:echinocandin B